$ Value
$0
Shares
3,472
Price
$0
Filed
Apr 6
Insider
Name
Hopper Jonathan Mark
Title
Chief Medical Officer
CIK
0001626325
Roles
Transaction Details
Transaction Date
2026-04-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,132
Footnotes
These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). | The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025. | These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Filing Info
Hopper Jonathan Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-02 | VCEL | M | $38K |
| 2026-04-02 | VCEL | ▼ | $122K |
| 2026-04-02 | VCEL | M | $0 |
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | $0 |
| 2026-02-24 | VCEL | F | $51K |
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | $0 |
| 2026-02-24 | VCEL | F | $24K |
| 2026-02-24 | VCEL | M | — |
Other Insiders at VCEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MCLAUGHLIN KEVIN F | — | $243K | 2026-02-11 |
|
Colangelo Dominick
President and CEO
|
— | — | 2026-02-24 |
| Rubino Alan L | — | — | 2026-03-25 |
| Hagen Heidi | — | $486K | 2026-03-23 |
|
Hopper Jonathan Mark
Chief Medical Officer
|
— | $122K | 2026-04-02 |
|
Halpin Michael
Chief Operating Officer
|
— | $364K | 2026-03-02 |
|
Flynn Sean C.
Chief Legal Officer
|
— | $754K | 2026-03-02 |
|
Mara Joseph Anthony Jr
Chief Financial Officer
|
— | — | 2026-02-24 |
|
SIEGAL JONATHAN
Principal Accounting Officer
|
— | — | 2026-02-24 |